Achievement of treatment targets and maintenance of response with upadacitinib in patients with moderate-to-severe rheumatoid arthritis in real-world practice: 1-year outcomes from the UPHOLD observational study.
- DOI
- 10.1186/s13075-025-03528-5
- Published
- 2025 Apr 10
- Container
- Arthritis research & therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13075-025-03528-5,
title = {Achievement of treatment targets and maintenance of response with upadacitinib in patients with moderate-to-severe rheumatoid arthritis in real-world practice: 1-year outcomes from the UPHOLD observational study.},
author = {Östör A and Feist E and Sidiropoulos P and Avouac J and Rebella M and Namas R and McDearmon-Blondell E and Gao T and Lagunes-Galindo I and Strengholt S and Zisman D and Attar S},
year = {2025},
journal = {Arthritis research \& therapy},
doi = {10.1186/s13075-025-03528-5},
url = {https://doi.org/10.1186/s13075-025-03528-5}
}RIS
TY - JOUR TI - Achievement of treatment targets and maintenance of response with upadacitinib in patients with moderate-to-severe rheumatoid arthritis in real-world practice: 1-year outcomes from the UPHOLD observational study. AU - Östör A AU - Feist E AU - Sidiropoulos P AU - Avouac J AU - Rebella M AU - Namas R AU - McDearmon-Blondell E AU - Gao T AU - Lagunes-Galindo I AU - Strengholt S AU - Zisman D AU - Attar S PY - 2025 JO - Arthritis research & therapy DO - 10.1186/s13075-025-03528-5 UR - https://doi.org/10.1186/s13075-025-03528-5 ER -
APA
A, Ö., E, F., P, S., J, A., M, R., R, N., E, M., T, G., I, L., S, S., D, Z., & S, A. (2025). Achievement of treatment targets and maintenance of response with upadacitinib in patients with moderate-to-severe rheumatoid arthritis in real-world practice: 1-year outcomes from the UPHOLD observational study.. Arthritis research & therapy. https://doi.org/10.1186/s13075-025-03528-5
Source records
- pubmed · retrieved 2026-11-10T16:29:34.098Z